Stock Events

Stock Events

Ayala Pharmaceuticals 

$0.62
76
+$0.11+20.69% Monday 19:39

Statistics

Day High
0.1
Day Low
0.08
52W High
0.8
52W Low
0
Volume
10,014
Avg. Volume
4,845
Mkt Cap
26.24M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

25FebExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-369,784.62%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
26,000Revenue
-96.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ADXS. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap214.76B
Merck & Co. is a leading pharmaceutical company that competes with Ayala Pharmaceuticals in the oncology sector, particularly in developing treatments for various cancers.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb is a global biopharmaceutical company with a strong portfolio in cancer treatments, directly competing with Ayala Pharmaceuticals in the oncology market.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical corporation with a broad range of products including oncology, directly competing with Ayala Pharmaceuticals in cancer treatment research and development.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, including oncology, making it a direct competitor to Ayala Pharmaceuticals in cancer treatment innovations.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a major player in the pharmaceutical industry, especially in oncology, competing with Ayala Pharmaceuticals in the development of cancer treatments.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that focuses on developing medicines for life-threatening illnesses, including cancer, making it a competitor to Ayala Pharmaceuticals.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company engaged in the discovery, development, and delivery of innovative human therapeutics, including cancer treatments, competing with Ayala Pharmaceuticals.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a biopharmaceutical company with a significant focus on oncology, making it a direct competitor to Ayala Pharmaceuticals in the field of cancer treatment.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including for cancer, competing with Ayala Pharmaceuticals.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals is a leading biotechnology company that develops and commercializes medicines for the treatment of serious medical conditions, including oncology, making it a competitor to Ayala Pharmaceuticals.

About

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.
Show more...
CEO
Mr. Kenneth A. Berlin J.D.
Employees
20
Country
US
ISIN
US0076244062

Listings

OTC Link
US
ADXS

0 Comments

Share your thoughts

FAQ

What is Ayala Pharmaceuticals stock price today?▼
The current price of ADXS is $0.62 USD — it has increased by +20.69% in the past 24 hours. Watch Ayala Pharmaceuticals stock price performance more closely on the chart.
What is Ayala Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ayala Pharmaceuticals stocks are traded under the ticker ADXS.
Is Ayala Pharmaceuticals stock price growing?▼
ADXS stock has risen by +75.86% compared to the previous week, the month change is a +678.13% rise, over the last year Ayala Pharmaceuticals has showed a +2,055.87% increase.
What is Ayala Pharmaceuticals market cap?▼
Today Ayala Pharmaceuticals has the market capitalization of 26.24M
When is the next Ayala Pharmaceuticals earnings date?▼
Ayala Pharmaceuticals is going to release the next earnings report on February 25, 2026.
What is Ayala Pharmaceuticals revenue for the last year?▼
Ayala Pharmaceuticals revenue for the last year amounts to 26,000 USD.
What is Ayala Pharmaceuticals net income for the last year?▼
ADXS net income for the last year is -96.14M USD.
How many employees does Ayala Pharmaceuticals have?▼
As of February 03, 2026, the company has 20 employees.
In which sector is Ayala Pharmaceuticals located?▼
Ayala Pharmaceuticals operates in the Health Care sector.
When did Ayala Pharmaceuticals complete a stock split?▼
The last stock split for Ayala Pharmaceuticals was on June 06, 2022 with a ratio of 1:80.
Where is Ayala Pharmaceuticals headquartered?▼
Ayala Pharmaceuticals is headquartered in Wilmington, US.